These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8258682)
21. Intrathymic radioresistant stem cells follow an IL-2/IL-2R pathway during thymic regeneration after sublethal irradiation. Zúñiga-Pflücker JC; Kruisbeek AM J Immunol; 1990 May; 144(10):3736-40. PubMed ID: 2110211 [TBL] [Abstract][Full Text] [Related]
22. Fetal liver contains committed NK progenitors, but is not a site for development of CD34+ cells into T cells. Jaleco AC; Blom B; Res P; Weijer K; Lanier LL; Phillips JH; Spits H J Immunol; 1997 Jul; 159(2):694-702. PubMed ID: 9218584 [TBL] [Abstract][Full Text] [Related]
23. Interleukin-1 augments the interleukin-2-dependent generation of natural killer cells from bone marrow precursors. Migliorati G; Cannarile L; D'Adamio L; Herberman RB; Riccardi C Nat Immun Cell Growth Regul; 1987; 6(6):306-15. PubMed ID: 3502358 [TBL] [Abstract][Full Text] [Related]
24. Functional and phenotypic analysis of thymocytes in SCID mice. Evidence for functional response transitions before and after the SCID arrest point. Rothenberg EV; Chen D; Diamond RA J Immunol; 1993 Oct; 151(7):3530-46. PubMed ID: 8376791 [TBL] [Abstract][Full Text] [Related]
25. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets. Lebow LT; Jewett A; Bonavida B J Immunol; 1993 Jan; 150(1):320-9. PubMed ID: 8417130 [TBL] [Abstract][Full Text] [Related]
26. Control of prothymocyte proliferation by thymic accessory cells. Papiernik M; Penit C; el Rouby S Eur J Immunol; 1987 Sep; 17(9):1303-10. PubMed ID: 3498636 [TBL] [Abstract][Full Text] [Related]
27. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Gaddy J; Broxmeyer HE Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743 [TBL] [Abstract][Full Text] [Related]
28. The expression of IL-2R alpha-chain is enhanced by activation of adenylate cyclase in large granular lymphocytes and natural killer cells. Koyasu S; Tagaya Y; Sugie K; Yonehara S; Yodoi J; Yahara I J Immunol; 1991 Jan; 146(1):233-8. PubMed ID: 1845805 [TBL] [Abstract][Full Text] [Related]
30. Recombinant interleukin 4 promotes the growth of human T cells. Spits H; Yssel H; Takebe Y; Arai N; Yokota T; Lee F; Arai K; Banchereau J; de Vries JE J Immunol; 1987 Aug; 139(4):1142-7. PubMed ID: 3497196 [TBL] [Abstract][Full Text] [Related]
31. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine). Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674 [TBL] [Abstract][Full Text] [Related]
32. Natural killer cells from protein kinase C theta-/- mice stimulated with interleukin-12 are deficient in production of interferon-gamma. Page KM; Chaudhary D; Goldman SJ; Kasaian MT J Leukoc Biol; 2008 May; 83(5):1267-76. PubMed ID: 18263766 [TBL] [Abstract][Full Text] [Related]
33. Role for IL-15/IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development. Ohteki T; Ho S; Suzuki H; Mak TW; Ohashi PS J Immunol; 1997 Dec; 159(12):5931-5. PubMed ID: 9550390 [TBL] [Abstract][Full Text] [Related]
34. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells. Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292 [TBL] [Abstract][Full Text] [Related]
35. IL-2 responsiveness of CD4 and CD8 lymphocytes: further investigations with human IL-2Rbeta transgenic mice. Gesbert F; Moreau JL; Thèze J Int Immunol; 2005 Aug; 17(8):1093-102. PubMed ID: 16037071 [TBL] [Abstract][Full Text] [Related]
36. Changes in tumor-associated NK 1.1+ large granular lymphocyte precursors after cyclophosphamide injection: in vitro characterization and potential therapeutic application. Krupke DM; Fuller J; Aslakson C; Evans R Nat Immun; 1994; 13(5):246-57. PubMed ID: 7833624 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity. Hafner M; Falk W; Echtenacher B; Männel DN Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121 [TBL] [Abstract][Full Text] [Related]
38. Induction of phenotypic differentiation, interleukin 2 production, and PHA responsiveness of "immature" human thymocytes by interleukin 1 and phorbol ester. de Vries JE; Vyth-Dreese FA; Figdor CG; Spits H; Leemans JM; Bont WS J Immunol; 1983 Jul; 131(1):201-6. PubMed ID: 6408170 [TBL] [Abstract][Full Text] [Related]
39. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients. Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731 [TBL] [Abstract][Full Text] [Related]
40. The relative roles of interleukins 1, 2, and 3 in the regulation of T cell differentiation. Ihle JN; Keller J Kroc Found Ser; 1984; 18():399-421. PubMed ID: 6442348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]